指南与共识胸部肿瘤

ASCO 2026版Ⅳ期无驱动基因非小细胞肺癌治疗指南

Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.1.
指南 / 共识 · J Clin Oncol · 2026-05-26

该文为ASCO发布的Ⅳ期无驱动基因突变非小细胞肺癌治疗活指南2026.3.1版,由常设专家小组持续系统检索文献并定期更新推荐,但摘要未报告具体推荐条款、研究数据或更新内容。

要点

  • 活指南针对证据快速演变的领域,由常设专家小组持续审查文献并定期更新。
  • 本版本为2026.3.1版,聚焦Ⅳ期无驱动基因突变非小细胞肺癌的治疗推荐。
  • 摘要未给出具体治疗推荐、疗效数值或证据等级,需查阅全文更新内容。

核心结论

  • 该活指南旨在为Ⅳ期无驱动基因突变非小细胞肺癌的治疗提供定期更新的推荐,但摘要未报告具体结论。

研究设计与样本

  • 由ASCO常设专家小组基于持续系统文献审查制定并定期更新的活指南,摘要未报告具体方法学细节。

临床怎么用

  • 临床医生应查阅该活指南全文及定期更新内容以获取当前治疗推荐,并结合患者个体情况独立判断。

局限性

  • 活指南不替代治疗医生的独立专业判断,且未考虑患者个体差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual. ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines. Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See appendix for disclaimers and other important information (Appendix 1 and Appendix 2, online only). Updates are published regularly and can be found at https://ascopubs.org/nsclc-non-da-living-guideline.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Bazhenova L, Ismaila N, Durm G, et al. Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.1. J Clin Oncol. 2026. PMID: 42190141. doi:10.1200/JCO-26-00842

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。